Daniel H. Park

1.0k total citations
11 papers, 126 citations indexed

About

Daniel H. Park is a scholar working on Oncology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Daniel H. Park has authored 11 papers receiving a total of 126 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 7 papers in Immunology and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Daniel H. Park's work include CAR-T cell therapy research (6 papers), Immunotherapy and Immune Responses (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Daniel H. Park is often cited by papers focused on CAR-T cell therapy research (6 papers), Immunotherapy and Immune Responses (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Daniel H. Park collaborates with scholars based in United States, China and Uganda. Daniel H. Park's co-authors include David B. Weiner, Kevin Liaw, Margaret M. Chou, Devivasha Bordoloi, Ryan P. O’Connell, Pratik Bhojnagarwala, Kanika Jain, Michael D. Farwell, Mark A. Sellmyer and Gerd A. Blobel and has published in prestigious journals such as Cancer Research, Frontiers in Immunology and Molecular Therapy.

In The Last Decade

Daniel H. Park

10 papers receiving 125 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel H. Park United States 6 56 56 48 28 16 11 126
Sunjong Ji United States 6 45 0.8× 37 0.7× 30 0.6× 20 0.7× 17 1.1× 12 121
Ben S. Wendel United States 6 38 0.7× 132 2.4× 43 0.9× 18 0.6× 14 0.9× 9 180
Christina K. Baumgartner United States 11 46 0.8× 86 1.5× 55 1.1× 13 0.5× 41 2.6× 17 221
E. Lake Potter United States 6 80 1.4× 122 2.2× 89 1.9× 13 0.5× 17 1.1× 8 237
Jeanette M. Pots Netherlands 8 77 1.4× 150 2.7× 101 2.1× 13 0.5× 12 0.8× 11 241
Tobias Schoep Australia 4 32 0.6× 54 1.0× 68 1.4× 50 1.8× 7 0.4× 6 151
Ping‐Yi Wu Taiwan 7 72 1.3× 109 1.9× 60 1.3× 9 0.3× 36 2.3× 9 193
Christopher Paustian United States 8 97 1.7× 152 2.7× 68 1.4× 14 0.5× 35 2.2× 24 221
Michael B. McAndrew United Kingdom 3 20 0.4× 71 1.3× 74 1.5× 47 1.7× 8 0.5× 5 161

Countries citing papers authored by Daniel H. Park

Since Specialization
Citations

This map shows the geographic impact of Daniel H. Park's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel H. Park with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel H. Park more than expected).

Fields of papers citing papers by Daniel H. Park

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel H. Park. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel H. Park. The network helps show where Daniel H. Park may publish in the future.

Co-authorship network of co-authors of Daniel H. Park

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel H. Park. A scholar is included among the top collaborators of Daniel H. Park based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel H. Park. Daniel H. Park is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
O’Connell, Ryan P., Kevin Liaw, Nils Wellhausen, et al.. (2024). Format-tuning of in vivo-launched bispecific T cell engager enhances efficacy against renal cell carcinoma. Journal for ImmunoTherapy of Cancer. 12(6). e008733–e008733. 6 indexed citations
2.
Park, Daniel H., Pratik Bhojnagarwala, Kevin Liaw, et al.. (2024). Novel tri-specific T-cell engager targeting IL-13Rα2 and EGFRvIII provides long-term survival in heterogeneous GBM challenge and promotes antitumor cytotoxicity with patient immune cells. Journal for ImmunoTherapy of Cancer. 12(12). e009604–e009604. 4 indexed citations
3.
4.
Park, Daniel H., Kevin Liaw, Pratik Bhojnagarwala, et al.. (2023). Multivalent in vivo delivery of DNA-encoded bispecific T cell engagers effectively controls heterogeneous GBM tumors and mitigates immune escape. Molecular Therapy — Oncolytics. 28. 249–263. 11 indexed citations
5.
Tursi, Nicholas J., Ziyang Xu, Susanne N. Walker, et al.. (2023). Engineered antibody cytokine chimera synergizes with DNA-launched nanoparticle vaccines to potentiate melanoma suppression in vivo. Frontiers in Immunology. 14. 1072810–1072810. 3 indexed citations
6.
Bordoloi, Devivasha, Pratik Bhojnagarwala, Alfredo Perales‐Puchalt, et al.. (2022). A mAb against surface-expressed FSHR engineered to engage adaptive immunity for ovarian cancer immunotherapy. JCI Insight. 7(22). 14 indexed citations
7.
Edwards, Kimberly J., et al.. (2022). Using CD69 PET Imaging to Monitor Immunotherapy-Induced Immune Activation. Cancer Immunology Research. 10(9). 1084–1094. 21 indexed citations
8.
Jain, Kanika, Robert Young, Laura Quick, et al.. (2021). Ubiquitin-Specific Protease 6 Functions as a Tumor Suppressor in Ewing Sarcoma through Immune Activation. Cancer Research. 81(8). 2171–2183. 24 indexed citations
9.
Zhu, Xizhou, Alfredo Perales‐Puchalt, Ziyang Xu, et al.. (2021). DNA immunotherapy targeting BARF1 induces potent anti-tumor responses against Epstein-Barr-virus-associated carcinomas. Molecular Therapy — Oncolytics. 24. 218–229. 5 indexed citations
10.
Elliott, Sarah T. C., Nicole L. Kallewaard, Ebony Benjamin, et al.. (2017). DMAb inoculation of synthetic cross reactive antibodies protects against lethal influenza A and B infections. npj Vaccines. 2(1). 18–18. 37 indexed citations
11.
Patel, Ami, Seleeke Flingai, Sarah T. C. Elliott, et al.. (2016). 264. In Vivo DNA-Monoclonal Antibody (DMAb) Gene Delivery Protects Against Lethal Bacterial and Viral Challenges in Mice. Molecular Therapy. 24. S105–S105. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sunjong Ji Breakdown of academic impact, for papers by Ben S. Wendel Breakdown of academic impact, for papers by Christina K. Baumgartner Breakdown of academic impact, for papers by E. Lake Potter Breakdown of academic impact, for papers by Jeanette M. Pots Breakdown of academic impact, for papers by Tobias Schoep Breakdown of academic impact, for papers by Ping‐Yi Wu Breakdown of academic impact, for papers by Christopher Paustian Breakdown of academic impact, for papers by Michael B. McAndrew
Rankless by CCL
2026